Technical Analysis for ALNA - Allena Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 8.85 -4.43% -0.41
ALNA closed down 4.43 percent on Monday, December 10, 2018, on 74 percent of normal volume. It ran into resistance at its 50 day moving average.

Earnings due: Dec 13

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ALNA trend table...

Date Alert Name Type % Chg
Dec 10 50 DMA Resistance Bearish 0.00%
Dec 10 20 DMA Support Bullish 0.00%
Dec 7 50 DMA Resistance Bearish -4.43%
Dec 7 New Uptrend Bullish -4.43%
Dec 7 NR7 Range Contraction -4.43%
Dec 7 NR7-2 Range Contraction -4.43%
Dec 6 NR7 Range Contraction -3.17%
Dec 4 Fell Below 50 DMA Bearish -3.80%
Dec 4 Wide Bands Range Expansion -3.80%
Dec 3 Crossed Above 50 DMA Bullish -6.35%

Older signals for ALNA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Allena Pharmaceuticals, Inc. is a United States-based specialty biopharmaceutical company. The Company is focused on developing and commercializing non-systemic oral protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions. Its lead product candidate, ALLN-177, is in an ongoing Phase II clinical trial and is being developed for the chronic management of hyperoxaluria and kidney stones. ALLN-177 is an orally administered, recombinant oxalate-degrading enzyme. ALLN-177 targets oxalate in the gastrointestinal (GI) tract to reduce the burden of both dietary and endogenously produced oxalate. ALLN-177 has the potential to decrease the oxalate available systemically for deposition as calcium oxalate crystals or stones in the kidneys, as well as to reduce the incidence of calcium oxalate related complications. Its technological approach enables the design and development of oral protein therapies that remain in the GI tract.
Is ALNA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.56
52 Week Low 6.13
Average Volume 25,681
200-Day Moving Average 11.2904
50-Day Moving Average 9.3238
20-Day Moving Average 8.818
10-Day Moving Average 9.288
Average True Range 0.7869
ADX 25.53
+DI 22.2131
-DI 13.7922
Chandelier Exit (Long, 3 ATRs ) 8.2993
Chandelier Exit (Short, 3 ATRs ) 9.8207
Upper Bollinger Band 10.0237
Lower Bollinger Band 7.6123
Percent B (%b) 0.51
BandWidth 27.346337
MACD Line 0.0552
MACD Signal Line -0.0055
MACD Histogram 0.0607
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.99
Resistance 3 (R3) 10.06 9.74 9.80
Resistance 2 (R2) 9.74 9.45 9.71 9.74
Resistance 1 (R1) 9.30 9.27 9.14 9.23 9.67
Pivot Point 8.98 8.98 8.91 8.95 8.98
Support 1 (S1) 8.54 8.69 8.38 8.47 8.03
Support 2 (S2) 8.22 8.51 8.19 7.96
Support 3 (S3) 7.78 8.22 7.90
Support 4 (S4) 7.71